Integra LifeSciences Corp.

Company Overview

Integra LifeSciences Corp. is a global medical technology company that develops innovative therapeutic approaches to enhance patient outcomes and establish new benchmarks in neurologic, surgical, ear, nose, and throat (ENT), and regenerative care. It has developed several product lines, ranging from treatments for deep-tissue wounds and burns to those for healing the brain's dura mater, nerves, and tendons. Through international acquisitions and product development, it has expanded its core regenerative technology business to include ENT, surgical instruments, neurosurgical devices, and advanced wound care. Its products are offered in over 120 countries through distributors, wholesalers, and a direct sales staff. Codman Specialty Surgical (CSS) and Tissue Technology (TT) are the two reportable business segments. The TT segment focuses on peripheral nerve repair, surgical reconstruction, and the management of complex wounds. Key manufacturing and research centers of Integra are in California, Maryland, Massachusetts, New Jersey, Ohio, Puerto Rico, Tennessee, Utah, as well as in France, Germany, Ireland, Israel, and Switzerland.

Financial Highlights (FY 2025)

Company's Business Segments

• Codman Specialty Surgical : Technologies and instrumentation used for a wide range of specialties such as Neurosurgery Neurocritical care and Otolaryngology
• Tissue Technologies : Complex wound surgery, Surgical reconstruction, Peripheral nerve repair